Abe Yoshiyuki, Tamura Katsumi, Sakata Ikuko, Ishida Jiro, Mukai Masaya, Ohtaki Makoto, Nakamura Masato, Machida Kikuo
Tokorozawa PET Diagnostic Imaging Clinic, Saitama 359-1124.
Oncol Lett. 2010 Jul;1(4):605-607. doi: 10.3892/ol_00000107. Epub 2010 Jul 1.
Patients with primary pancreatic lymphoma (PPL), which is rare, require a different therapeutic approach and have a better prognosis than those with pancreatic cancer. However, conventional imaging modalities alone are not able to differentiate between pancreatic cancer and other rare tumors such as PPL, although the accurate diagnosis of PPL is crucial. The development of new modalities such as F-18 2'-deoxy-2fluoro-D-glucose (FDG) positron emission tomography combined with computed tomography (PET/CT) contributes to the evaluation of lymphoma staging. However, few reports are currently available regarding PET/CT findings in PPL. In this study, a 56-year old man with PPL was examined using FDG PET/CT imaging, which showed the unique intense uptake of FDG in the pancreas with atypical findings of malignancy in the CT scan and magnetic resonance images.
原发性胰腺淋巴瘤(PPL)患者较为罕见,其治疗方法与胰腺癌患者不同,且预后较好。然而,尽管准确诊断PPL至关重要,但仅依靠传统成像方式无法区分胰腺癌和其他罕见肿瘤,如PPL。新型成像方式如F-18 2'-脱氧-2-氟-D-葡萄糖(FDG)正电子发射断层扫描联合计算机断层扫描(PET/CT)的发展有助于评估淋巴瘤分期。然而,目前关于PPL的PET/CT表现的报道较少。在本研究中,一名56岁的PPL男性患者接受了FDG PET/CT成像检查,结果显示胰腺中FDG摄取异常强烈,CT扫描和磁共振图像中有非典型恶性表现。